Clinical Trials
21
Active:0
Completed:11
Trial Phases
3 Phases
Phase 2:2
Phase 3:2
Not Applicable:17
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
Not Applicable
17 (81.0%)Phase 2
2 (9.5%)Phase 3
2 (9.5%)Quadriceps Strengthening At Different Angles in Patellofemoral Pain
Not Applicable
Recruiting
- Conditions
- Patellofemoral Pain Syndrome
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Universidade Federal do Ceara
- Target Recruit Count
- 110
- Registration Number
- NCT06502795
- Locations
- 🇧🇷
Physiotherapy Department, Federal University of Ceará, Fortaleza, Ceará, Brazil
Impact of SGLT2 Inhibitors in Heart Transplant Recipients
Phase 2
- Conditions
- Rejection Heart TransplantTransplant; Failure, HeartCardiac Allograft Vasculopathy
- Interventions
- Drug: SGLT2i
- First Posted Date
- 2023-11-27
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Universidade Federal do Ceara
- Target Recruit Count
- 80
- Registration Number
- NCT06147271
- Locations
- 🇧🇷
Messejana Hospital, Fortaleza, Ceara, Brazil
Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19
Phase 3
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2021-06-30
- Lead Sponsor
- Universidade Federal do Ceara
- Target Recruit Count
- 219
- Registration Number
- NCT04928495
- Locations
- 🇧🇷
Núcleo de Biomedicina - NUBIMED, Fortaleza, Ceará, Brazil
Effect of Low Intensity Training Combined With Partial Restriction of Blood Flow in Individuals With Knee Osteoarthritis
Not Applicable
Not yet recruiting
- Conditions
- Osteoarthritis, Knee
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Universidade Federal do Ceara
- Target Recruit Count
- 66
- Registration Number
- NCT04819672
Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19
Not Applicable
- Conditions
- Covid19
- Interventions
- Drug: Vitamin C 500 MG Oral Tablet
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Universidade Federal do Ceara
- Target Recruit Count
- 219
- Registration Number
- NCT04712357
- Locations
- 🇧🇷
Núcleo de Biomedicina - NUBIMED, Fortaleza, Ceará, Brazil
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found